268 related articles for article (PubMed ID: 33592065)
21. Modelling BK Polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells.
Lorentzen EM; Henriksen S; Rinaldo CH
PLoS Pathog; 2023 Aug; 19(8):e1011622. PubMed ID: 37639485
[TBL] [Abstract][Full Text] [Related]
22. Establishment of COS-BK cells persistently infected with archetype BK polyomavirus.
Nukuzuma S; Onogi H; Suzuki T
Microbiol Immunol; 2024 May; 68(5):179-184. PubMed ID: 38433377
[TBL] [Abstract][Full Text] [Related]
23. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
25. Perception, diagnosis and management of BK polyomavirus replication and disease in paediatric kidney transplant recipients in Europe.
Pape L; Tönshoff B; Hirsch HH;
Nephrol Dial Transplant; 2016 May; 31(5):842-7. PubMed ID: 26590390
[TBL] [Abstract][Full Text] [Related]
26. Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution.
Peretti A; Geoghegan EM; Pastrana DV; Smola S; Feld P; Sauter M; Lohse S; Ramesh M; Lim ES; Wang D; Borgogna C; FitzGerald PC; Bliskovsky V; Starrett GJ; Law EK; Harris RS; Killian JK; Zhu J; Pineda M; Meltzer PS; Boldorini R; Gariglio M; Buck CB
Cell Host Microbe; 2018 May; 23(5):628-635.e7. PubMed ID: 29746834
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a BK polyomavirus serotyping assay using Luminex technology.
Wunderink HF; de Brouwer CS; van der Meijden E; Pastrana DV; Kroes ACM; Buck CB; Feltkamp MCW
J Clin Virol; 2019 Jan; 110():22-28. PubMed ID: 30529638
[TBL] [Abstract][Full Text] [Related]
28. The human fetal glial cell line SVG p12 contains infectious BK polyomavirus.
Henriksen S; Tylden GD; Dumoulin A; Sharma BN; Hirsch HH; Rinaldo CH
J Virol; 2014 Jul; 88(13):7556-68. PubMed ID: 24760884
[TBL] [Abstract][Full Text] [Related]
29. BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy.
Bruminhent J; Srisala S; Klinmalai C; Pinsai S; Watcharananan SP; Kantachuvesiri S; Hongeng S; Apiwattanakul N
BMC Infect Dis; 2019 Nov; 19(1):974. PubMed ID: 31744480
[TBL] [Abstract][Full Text] [Related]
30. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
31. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
32. Clinically Relevant Reactivation of Polyomavirus BK (BKPyV) in HLA-A02-Positive Renal Transplant Recipients Is Associated with Impaired Effector-Memory Differentiation of BKPyV-Specific CD8+ T Cells.
van Aalderen MC; Remmerswaal EB; Heutinck KM; Ten Brinke A; Feltkamp MC; van der Weerd NC; van der Pant KA; Bemelman FJ; van Lier RA; Ten Berge IJ
PLoS Pathog; 2016 Oct; 12(10):e1005903. PubMed ID: 27723787
[TBL] [Abstract][Full Text] [Related]
33. Interaction Between Human Polyomavirus BK and Hypoxia Inducible Factor-1 alpha.
Signorini L; Croci M; Boldorini R; Varella RB; Elia F; Carluccio S; Villani S; Bella R; Ferrante P; Delbue S
J Cell Physiol; 2016 Jun; 231(6):1343-9. PubMed ID: 26529465
[TBL] [Abstract][Full Text] [Related]
34. BK polyomavirus in kidney transplant recipients: screening, monitoring and clinical management.
Varella RB; Almeida JR; Lopes Pde F; Matos JP; Menezes P; Lugon JR
J Bras Nefrol; 2014; 36(4):529-34. PubMed ID: 25517283
[TBL] [Abstract][Full Text] [Related]
35. Impact of immune suppressive agents on the BK-Polyomavirus non coding control region.
Korth J; Anastasiou OE; Verheyen J; Dickow J; Sertznig H; Frericks N; Bleekmann B; Kribben A; Brinkhoff A; Wilde B; Sutter K; Dittmer U; Ciesek S; Witzke O; Widera M
Antiviral Res; 2018 Nov; 159():68-76. PubMed ID: 30268912
[TBL] [Abstract][Full Text] [Related]
36. Concurrent cytomegalovirus glomerulitis and BK polyomavirus-associated nephropathy in a kidney allograft biopsy.
Chikeka IO; Paulk A; Haririan A; Papadimitriou JC; Drachenberg CB
Transpl Infect Dis; 2016 Apr; 18(2):247-50. PubMed ID: 26782090
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of BK virus replication in human kidney cells by BK virus large tumor antigen-specific shRNA delivered by JC virus-like particles.
Lin MC; Wang M; Fang CY; Chen PL; Shen CH; Chang D
Antiviral Res; 2014 Mar; 103():25-31. PubMed ID: 24406668
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of serum IgG antibodies reacting to specific mimotopes of BK polyomavirus, a human oncogenic polyomavirus, in patients affected by uveal melanoma.
Bononi I; Mazzoni E; Pietrobon S; Torreggiani E; Rossini M; Violanti S; Perri P; Tognon M; Martini F
J Cell Physiol; 2018 Dec; 233(12):9052-9059. PubMed ID: 29968911
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of polyoma BK virus infection among living-donor renal transplant recipients.
El Ansary M; Abd Elhamid S; Saadi G; Ismail W; Ibrahim N; Bahaa El-Din N; Alhsyek S
Transpl Infect Dis; 2016 Aug; 18(4):529-37. PubMed ID: 27226063
[TBL] [Abstract][Full Text] [Related]
40. The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation.
Korth J; Anastasiou OE; Bräsen JH; Brinkhoff A; Lehmann U; Kribben A; Dittmer U; Verheyen J; Wilde B; Ciesek S; Witzke O; Widera M
J Clin Virol; 2019 Apr; 113():14-19. PubMed ID: 30771597
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
